PolyPid Ltd.
PYPD- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001611842
No open-market purchases or sales by PolyPid Ltd. insiders were filed in the last 90 days; 33 institutions reported holding it in 13F filings for Q2 2026, worth $16.7M in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding PolyPid Ltd. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 14 | 4 | −10 |
| Shares | 424.1K | 20.3K | −403.7K (−95.2%) |
| Value | $155.2K | $93.2K | −$62.1K (−40.0%) |
New holders (1)
Institutions that held PolyPid Ltd. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Yelin Lapidot Holdings Management Ltd. | 11,154 | $51.9K | 0.01% |
Sold out (11)
Institutions that held PolyPid Ltd. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Boothbay Fund Management, LLC | 121,898 | $44.5K |
| Raymond James Financial Services Advisors, Inc. | 38,886 | $14.2K |
| Susquehanna International Group, LLP | 37,344 | $13.6K |
| Ewa, LLC | 37,113 | $13.5K |
| Two Sigma Securities, LLC | 33,220 | $12.1K |
| Renaissance Technologies LLC | 28,810 | $11.0K |
| Millennium Management LLC | 20,862 | $7.62K |
| Cerity Partners LLC | 18,709 | $6.83K |
| Geode Capital Management, LLC | 12,545 | $4.58K |
| UBS Group AG | 1,000 | $365 |
| Royal Bank of Canada | 147 | $0 |